ACW | Small Caps

Actinogen Medical ASX ACW cognitive improvement Xanamem XanaHES Alzheimer’s disease neurological

Actinogen Medical announces ‘breakthrough’ study results for Alzheimer’s drug Xanamem

October 1, 2019

Actinogen Medical (ASX: ACW) has announced “breakthrough” results from its XanaHES higher dose safety study first initiated last year. The results reaffirm the foundational hypothesis that reducing...

Read more

Actinogen Medical ASX ACW Phase 2 Alzheimer's disease trial results fail dementia

Actinogen Medical phase two Alzheimer’s clinical trial disappoints

May 7, 2019

Biotech company Actinogen Medical (ASX: ACW) has reported a mixed bag of results including some disappointing outcomes from its XanADu phase two clinical trial treating patients with mild dementia due...

Read more

Actinogen Medical ASX ACW US biotech investor Alzheimer’s XanADu study

Actinogen Medical attracts US biotech investor as Alzheimer’s XanADu study remains on track

May 23, 2018

Actinogen Medical (ASX: ACW) has received a double-shot of positive news earlier today after the biotech company received the all-clear from the Data Safety and Monitoring Board (DSMB) to continue its...

Read more

Actinogen Medical ASX ACW XanADu treat Alzheimer’s disease

Actinogen moves towards XanADu starting line to treat Alzheimer’s disease

March 21, 2018

Biotech company Actinogen Medical (ASX: ACW) has confirmed that it has obtained half of the required patients in order to conduct its landmark Phase 2 clinical trial of Xanamem, a drug candidate to tr...

Read more

RECENT POSTS

Market without Trump January 2021 ASX Afterpay commodities

Weekly review: market ponders the future without Trump

January 16, 2021

Venus Metals ASX VMC Sandstone project gold drilling

Venus Metals hits high grade gold at historic Sandstone project

January 15, 2021

Blackstone Minerals Codrus Minerals IPO ASX gold projects

Blackstone Minerals to spin out non-core gold projects into Codrus Minerals IPO

January 15, 2021

Lithium sector acquisition deals price rises 2021 ASX

Lithium sector springs back to life amid acquisition deals and price rises

January 15, 2021

STOCK SUMMARY

INVESTOR TOOLS

FOLLOW US

HOT TOPICS

Market without Trump January 2021 ASX Afterpay commodities

Weekly review: market ponders the future without Trump

January 16, 2021

Lithium sector acquisition deals price rises 2021 ASX

Lithium sector springs back to life amid acquisition deals and price rises

January 15, 2021

Credit card Afterpay interest market share debt

Goodbye credit card, hello Afterpay

January 13, 2021

TRENDING POSTS

Lithium sector acquisition deals price rises 2021 ASX

Lithium sector springs back to life amid acquisition deals and price rises

Eclipse Metals ASX EPM Ivittuut cryolite Greenland

Eclipse Metals acquires world’s largest historical cryolite mine, contains heavy rare earths

Vulcan Energy ASX VUL zero carbon lithium germany Europe PFS JORC

Vulcan Energy aims to be world’s first zero carbon lithium producer after positive PFS

Venus Metals ASX VMC Sandstone project gold drilling

Venus Metals hits high grade gold at historic Sandstone project

Market without Trump January 2021 ASX Afterpay commodities

Weekly review: market ponders the future without Trump

Credit card Afterpay interest market share debt

Goodbye credit card, hello Afterpay

Lithium stocks ASX

Lithium stocks on the ASX: The Ultimate Guide

Galan Lithium Greenbushes South Lithium Australia ASX GLN LIT

Galan Lithium to acquire 80% of Greenbushes South from Lithium Australia

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.